Amanote Research
Register
Sign In
Gadolinium-Based Hybrid Nanoparticles as a Positive MR Contrast Agent
doi 10.1021/ja066442d.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Silver and Gadolinium Ions Co-Substituted Hydroxyapatite Nanoparticles as Bimodal Contrast Agent for Medical Imaging
Bioceramics Development and Applications
Carbon Nanoparticles as a Multimodal Thermoacoustic and Photoacoustic Contrast Agent
Mesoporous Silica Nanoparticles as a Breast-Cancer Targeting Ultrasound Contrast Agent
Colloids and Surfaces B: Biointerfaces
Surfaces
Colloid
Interfaces
Theoretical Chemistry
Medicine
Biotechnology
Surface Chemistry
Physical
Heterodoped Nanoparticles as Dual-Mode Contrast Agent for MRI
Intracranial Distribution of Intravenously Administered Gadolinium-Based Contrast Agent Over a Period of 24 Hours: Evaluation With 3d-Real IR Imaging and MR Fingerprinting
Magnetic Resonance in Medical Sciences
Nuclear Medicine
Radiology
Imaging
Brain Gadolinium Deposition After Administration of Gadolinium-Based Contrast Agents
Japanese Journal of Radiology
Nuclear Medicine
Radiology
Imaging
Gadolinium Deposition in the Paediatric Brain: T1-Weighted Hyperintensity Within the Dentate Nucleus Following Repeated Gadolinium-Based Contrast Agent Administration
Clinical Radiology
Medicine
Nuclear Medicine
Radiology
Imaging
Targeted Fe-Doped Silica Nanoparticles as a Novel Ultrasound–magnetic Resonance Dual-Mode Imaging Contrast Agent for HER2-positive Breast Cancer
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Effect of Gadolinium on Phase-Contrast MR Angiography of the Renal Arteries.
American Journal of Roentgenology
Medicine
Nuclear Medicine
Radiology
Imaging
